Arsenic Trioxide Injection, Solution
Product Images NDC 70710-1895

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Arsenic Trioxide (NDC 70710-1895). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (B6e6e072 6d6b 47b1 Bc40 811fbd58ed03 01)

FDA Label Image

Arsenic Trioxide Injection, 1 mg/ml-vial Label (B6e6e072 6d6b 47b1 Bc40 811fbd58ed03 02)

Arsenic Trioxide Injection, 1 mg/ml-vial Label (B6e6e072 6d6b 47b1 Bc40 811fbd58ed03 02)
This is a medication with the NDC code 70710-1895-1, meant for intravenous use only as a cytotoxic agent. The container has a 2L capacity and is not made with natural rubber latex. It contains Arsenic Trioxide and should be stored at 25°C (77°F), with allowed excursions to 15-30°C (5%°F to 86°F). The medication is manufactured by Zydus Lifesciences Ltd in Ahmedabad, India and is distributed by Zydus Pharmaceuticals in the USA. The medication is a Novaplus product and comes in a 10mg/10mL single-dose vial. Any unused portion should be discarded, and the product is labeled with the trademark registration of Novaplus.*
FDA Label Image

Arsenic Trioxide Injection 1 mg/ml-carton Label (B6e6e072 6d6b 47b1 Bc40 811fbd58ed03 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.